View More View Less
  • 1 Laboratório de Oncologia Comparada e Translacional (LOCT), Departamento de Medicina Veterinária, Faculdade de Zootecnia e Engenharia de Alimentos, Universidade de São Paulo, Av. Duque de Caxias Norte 225, Jd. Elite, Pirassununga, CEP 13635-900, São Paulo, Brazil
  • | 2 Departamento de Patologia, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, SP, Brazil
  • | 3 Universidade Anhembi Morumbi, São Paulo, SP, Brazil
  • | 4 Universidade Paulista, São Paulo, SP, Brazil
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $836.00

Abstract

Mast cell tumour (MCT) is the most frequent skin neoplasm in dogs. These tumours are characterised by variable behaviour and clinical presentation that make prognosis an important and challenging task in the veterinary practice. Galectin-3 (Gal-3) is known to influence several biological processes that are important in the cancer context and has been described as a prognostic marker for several human cancers. The aim of the present work was to characterise Gal-3 immunolabelling in canine cutaneous MCTs and to investigate its value as a prognostic marker for the disease. Thirty-four random cases of canine cutaneous MCT that were surgically treated with wide margins were included in this study. Gal-3 expression was evaluated using immunohistochemistry and the results were compared with the expression of apoptosis-related proteins, Ki67 index, histopathological grades, mortality due to the disease and post-surgical survival. The majority of the MCTs (65.8%) were positive for Gal-3. Gal-3 immunolabelling was variable among the samples (2.7%–86.8% of the neoplastic cells). The protein was located in the cytoplasm or in the cytoplasm and the nucleus. Gal-3 positivity was correlated with BCL2 expression (P < 0.001; r = 0.604), but not with Ki67 and BAX. No significant differences were detected between histological grades or in the survival analysis. Gal-3 expression correlates with BCL2 expression in MCTs. Although an efficient marker for several human neoplasms, the results presented herein suggest that Gal-3 immunolabelling is not an independent prognostic indicator for this disease.

  • Akahani, S., Nangia-Makker, P., Inohara, H., Kim, H. R. and Raz, A. (1997): Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57 ,52725276.

    • Search Google Scholar
    • Export Citation
  • Barra, C. N., Macedo, B. M., Cadrobbi, K. G., Pulz, L. H., Huete, G. C., Kleeb, S. R., Xavier J. G., Catão-Dias, J. L., Nishiya, A. T., Fukumasu, H. and Strefezzi, R. F. (2018): Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours. Vet. Comp. Oncol. 16 ,E38E44.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Blackwood, L., Murphy, S., Buracco, P., De Vos, J. P., De Fornel-Thibaud, P., Hirschberger, J., Kessler, M., Pastor, J., Ponce, F., Savary-Bataille, K. and Argyle, D. J. (2012): European consensus document on mast cell tumours in dogs and cats. Vet. Comp. Oncol. 10 ,e1e29.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Chen, H-Y., Sharma, B. B., Yu, L., Zuberi, R., Weng., I-C., Kawakami, Y., Kawakami, T., Hsu, D. K. and Liu, F-T. (2006): Role of galectin-3 in mast cell functions: Galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. J. Immunol. 177 ,49914997.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Cheng, C. S., Dong, W. G., Luo, H. S. and Yu, B. P. (2004): Expression of galectin-3 and its significance in gastric carcinoma. Chin. J. Cancer Res. 16 ,176181.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Cohen, D., Reif, J. S., Brodey, R. S. and Keiser, H. (1974): Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res. 34 ,28592868.

    • Search Google Scholar
    • Export Citation
  • Davidson, P. J., Davis, M. J., Patterson, R. J., Ripoche, M-A., Poirier, F. and Wang, J. L. (2002): Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology 12 ,329337.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • De Oliveira, J. T., De Matos, A. I. F., Gomes, J., Vilanova, M., Hespanhol, V., Manninen, A., Rutteman, A., Chammas, R., Gärtner, F. and Bernardes, E. S. (2010): Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: Implications for tumor metastasis. Glycobiology 20 ,13411352.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Diao, B., Liu, Y., Xu, G. Z., Zhang, Y., Xie, J. and Gong, J. (2018): The role of galectin-3 in the tumorigenesis and progression of pituitary tumors. Oncol. Lett. 15 ,49194925.

    • Search Google Scholar
    • Export Citation
  • Dobson, J. M., Samuel, S., Milstein, H., Rogers, K. and Wood, J. L. N. (2002): Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J. Small Anim. Pract. 43 ,240246.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Dumic, J., Dabelic, S. and Flögel, M. (2006): Galectin-3: An open-ended story. Biochim. Biophys. Acta 1760 ,616635.

  • Elad-Sfadia, G., Haklai,. R, Balan, E., Kloog, Y. (2004): Galectin-3 augments K-ras activation and triggers a ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J. Biol. Chem. 279 ,3492234930.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Ellerhorst, J. A., Stephens, L. C., Nguyen, T. and Xu, X-C. (2002): Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP. Prostate 50 ,6470.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Endo, K., Kohnoe, S., Tsujita, E., Watanabe, A., Nakashima, H., Baba, H. and Maehara, Y. (2005): Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res. 25 ,31173121.

    • Search Google Scholar
    • Export Citation
  • Funasaka, T., Raz, A. and Nangia-Makker, P. (2014): Galectin-3 in angiogenesis and metastasis. Glycobiology 24 ,886891.

  • Harazono, Y., Kho, D. H., Balan, V., Nakajima, K., Zhang, T., Hogan, V. and Raz, A. (2014a): Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells. Oncotarget 5 ,999210001.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Harazono, Y., Nakajima, K. and Raz, A. (2014b): Why anti-Bcl-2 clinical trials fail: a solution. Cancer Metastasis Rev. 33 ,285294.

  • Huang, C-X., Hou, Y-H. and Liu, Y-S. (2008): Expression of galectin-3 correlates with apoptosis in pituitary adenoma cells. Neurosci. Bull. 24 ,3438.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Inohara, H. and Raz, A. (1995): Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res. 55 ,32673271.

    • Search Google Scholar
    • Export Citation
  • Kandefer-Gola, M., Nowak, M., Madej, J. A., Dzimira, S., Ciaputa, R. and Janus, I. (2015): Useful immunohistochemical indicators in canine mast cell tumours. Acta Vet. Hung. 63 ,4959.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Kim, H. R., Lin, H. M., Biliran, H. and Raz, A. (1999): Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res. 59 ,41484154.

    • Search Google Scholar
    • Export Citation
  • Kiupel, M. (2017): Mast cell tumors. In: Meuten, D. J. (ed.) Tumors in Domestic Animals. John Wiley & Sons, Inc., Ames, USA. pp. 176202.

    • Search Google Scholar
    • Export Citation
  • Kiupel, M., Webster, J. D., Bailey, K. L., Best, S., DeLay, J., Detrisac, C. J., Fitzgerald, S. D., Gamble, D., Ginn, P. E., Goldschmidt, M. H., Hendrick, M. J., Howerth, E. W., Janovitz, E. B., Langohr, I., Lenz, S. D., Lipscomb, T. P., Miller, M. A., Misdorp, W., Moroff, S., Mullaney, T. P., Neyens, I., O’Toole, D., Ramos-Vara, J., Scase, T. J., Schulman, F. Y., Sledge, D., Smedley, R. C., Smith, K., Snyder, P., Southorn, E., Stedman, N. L., Steficek, B. A., Stromberg, P. C., Valli, V. E., Weisbrode, S. E., Yager, J., Heller, J. and Miller, R. (2011): Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet. Pathol. 48 ,147155.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Liu, L., Sakai, T., Sano, N. and Fukui, K. (2004): Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling. Biochem. J. 380 ,3141.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • London, C. A. and Seguin, B. (2003): Mast cell tumors in the dog. Vet. Clin. North Am. Small Anim. Pract. 33 ,473489.

  • Mazurek, N., Conklin, J., Byrd, J. C., Raz, A. and Bresalier, R. S. (2000): Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J. Biol. Chem. 275 ,3631136315.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Nakahara, S., Oka, N. and Raz, A. (2005): On the role of galectin-3 in cancer apoptosis. Apoptosis 10 ,267275.

  • Okada, K., Shimura, T., Suehiro, T., Mochiki, E. and Kuwano, H. (2006): Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res. 26 ,13691376.

    • Search Google Scholar
    • Export Citation
  • Ose, R., Oharaa, O. and Nagase, T. (2012): Galectin-1 and galectin-3 mediate protocadherin-24-dependent membrane localization of β-catenin in colon cancer cell line HCT116. Curr. Chem. Genomics 6 ,1826.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Patnaik, A. K., Ehler, W. J. and MacEwen, E. G. (1984): Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet. Pathol. 21 ,469474.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Ribeiro, C., Santos, M. S., De Matos, A. J., Barros, R., Gärtner, F., Rutteman, G. R. and De Oliveira, J. T. (2016): Serum galectin-3 levels in dogs with metastatic and nonmetastatic mammary tumors. In Vivo 30 ,1316.

    • Search Google Scholar
    • Export Citation
  • Scase, T. J., Edwards, D., Miller, J., Henley, W., Smith, K., Blunden, A. and Murphy, S. (2006): Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J. Vet. Intern. Med. 20 ,151158.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Takenaka, Y., Fukumori, T., Yoshii, T., Oka, N., Inohara, H., Kim, H. R., Bresalier, R. S. and Raz, A. (2004): Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol. Cell Biol. 24 ,43954406.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Vargas, T. H. M., Pulz, L. H., Ferro, D. G., Sobral, R. A., Venturini, M. A. F. A., Corrêa, H. L. and Strefezzi, R. F. (2019): Galectin-3 expression correlates with post-surgical survival in canine oral melanomas. J. Comp. Pathol. 173 ,4957.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Vargas, T. H. M., Pulz, L. H. and Strefezzi, R. F. (2018): Immunohistochemical expression of galectin-3 in canine tumors. Braz. J. Vet. Pathol. 11 ,16.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Wang, Y., Naggia-Makker, P., Tait, L., Balan, V., Hogan, V., Pienta, K. J. and Raz, A. (2009): Regulation of prostate cancer progression by galectin-3. Am. J. Pathol. 174 ,15151523.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Welle, M. M., Bley, C. R., Howard, J. and Rufenacht, S. (2008): Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet. Dermatol. 19 ,321339.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Yu, F., Finley, R. L., Raz, A. and Kim, H-R. C. (2002): Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria – A role for synexin in galectin-3 translocation. J. Biol. Chem. 277 ,1581915827.

    • Crossref
    • Search Google Scholar
    • Export Citation

Author information is available in PDF.
Please, download the file from HERE.

The manuscript preparation instructions is available in PDF.
Please, download the file from HERE.

Senior editors

Editor-in-Chief: Mária BENKŐ

Managing Editor: András SZÉKELY

Editorial Board

  • Béla DÉNES (National Food Chain Safety Office, Budapest Hungary)
  • Edit ESZTERBAUER (Veterinary Medical Research Institute, Budapest, Hungary)
  • Hedvig FÉBEL (National Agricultural Innovation Centre, Herceghalom, Hungary)
  • László FODOR (University of Veterinary Medicine, Budapest, Hungary)
  • Balázs HARRACH (Veterinary Medical Research Institute, Budapest, Hungary)
  • Peter MASSÁNYI (Slovak University of Agriculture in Nitra, Nitra, Slovak Republic)
  • Béla NAGY (Veterinary Medical Research Institute, Budapest, Hungary)
  • Tibor NÉMETH (University of Veterinary Medicine, Budapest, Hungary)
  • Zsuzsanna NEOGRÁDY (University of Veterinary Medicine, Budapest, Hungary)
  • Alessandra PELAGALLI (University of Naples Federico II, Naples, Italy)
  • Kurt PFISTER (Ludwig-Maximilians-University of Munich, Munich, Germany)
  • László SOLTI (University of Veterinary Medicine, Budapest, Hungary)
  • József SZABÓ (University of Veterinary Medicine, Budapest, Hungary)
  • Péter VAJDOVICH (University of Veterinary Medicine, Budapest, Hungary)
  • János VARGA (University of Veterinary Medicine, Budapest, Hungary)
  • Štefan VILČEK (University of Veterinary Medicine in Kosice, Kosice, Slovak Republic)
  • Károly VÖRÖS (University of Veterinary Medicine, Budapest, Hungary)
  • Herbert WEISSENBÖCK (University of Veterinary Medicine, Vienna, Austria)
  • Attila ZSARNOVSZKY (Szent István University, Gödöllő, Hungary)

ACTA VETERINARIA HUNGARICA
Institute for Veterinary Medical Research
Centre for Agricultural Research
Hungarian Academy of Sciences
P.O. Box 18, H-1581 Budapest, Hungary
Phone: (36 1) 467 4081 (ed.-in-chief) or (36 1) 213 9793 (editor) Fax: (36 1) 467 4076 (ed.-in-chief) or (36 1) 213 9793

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Current Contents: Agriculture, Biology and Environmental Sciences
  • Elsevier Science Navigator
  • Focus On: Veterinary Science and Medicine
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Science Citation Index
  • Science Citation Index Expanded (SciSearch)
  • SCOPUS
  • The ISI Alerting Services
  • Zoological Abstracts

 

2020  
Total Cites 987
WoS
Journal
Impact Factor
0,955
Rank by Veterinary Sciences 101/146 (Q3)
Impact Factor  
Impact Factor 0,920
without
Journal Self Cites
5 Year 1,164
Impact Factor
Journal  0,57
Citation Indicator  
Rank by Journal  Veterinary Sciences 93/166 (Q3)
Citation Indicator   
Citable 49
Items
Total 49
Articles
Total 0
Reviews
Scimago 33
H-index
Scimago 0,395
Journal Rank
Scimago Veterinary (miscellaneous) Q2
Quartile Score  
Scopus 355/217=1,6
Scite Score  
Scopus General Veterinary 73/183 (Q2)
Scite Score Rank  
Scopus 0,565
SNIP  
Days from  145
sumbission  
to acceptance  
Days from  150
acceptance  
to publication  
Acceptance 19%
Rate

 

2019  
Total Cites
WoS
798
Impact Factor 0,991
Impact Factor
without
Journal Self Cites
0,897
5 Year
Impact Factor
1,092
Immediacy
Index
0,119
Citable
Items
59
Total
Articles
59
Total
Reviews
0
Cited
Half-Life
9,1
Citing
Half-Life
9,2
Eigenfactor
Score
0,00080
Article Influence
Score
0,253
% Articles
in
Citable Items
100,00
Normalized
Eigenfactor
0,09791
Average
IF
Percentile
42,606
Scimago
H-index
32
Scimago
Journal Rank
0,372
Scopus
Scite Score
335/213=1,6
Scopus
Scite Score Rank
General Veterinary 62/178 (Q2)
Scopus
SNIP
0,634
Acceptance
Rate
18%

 

Acta Veterinaria Hungarica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Printed Color Illustrations 40 EUR (or 10 000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 696 EUR / 872 USD
Print + online subscription: 804 EUR / 1004 USD
Subscription fee 2022 Online subsscription: 710 EUR / 892 USD
Print + online subscription: 824 EUR / 1028 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Veterinaria Hungarica
Language English
Size A4
Year of
Foundation
1951
Publication
Programme
2020 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-6290 (Print)
ISSN 1588-2705 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 0 0 0
Jun 2021 0 0 0
Jul 2021 0 0 0
Aug 2021 85 14 9
Sep 2021 53 2 2
Oct 2021 13 1 1
Nov 2021 0 0 0